MedPath

Observational Study to follow up patients enrolled in FIRST-Dx trial.

Not Applicable
Recruiting
Conditions
Chemotherapy-naive adult patients with advanced cancer (GI, Lung, Breast, GYN, Melanoma)
Registration Number
JPRN-jRCT1050220041
Lead Sponsor
Muto Manabu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

1. Registered in FIRST-Dx trial, and underwent F1CDx.
2. Written informed consent.

Exclusion Criteria

1. Withdrawal of informed consent.
2. Registered in FIRST-Dx trial, but failed in F1CDx.
3. Inappropriate case judged by investigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath